Tjip S van der Werf Selected Research

Streptomycin (Streptomycin Sulfate)

1/2020	Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
12/2016	Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management.
3/2015	In-vitro activity of avermectins against Mycobacterium ulcerans.
3/2014	Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial.
1/2013	Towards rational use of antibiotics for suspected secondary infections in Buruli ulcer patients.
2/2010	Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tjip S van der Werf Research Topics

Disease

39	Tuberculosis (Tuberculoses) 01/2022 - 03/2004
22	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020 - 02/2010
15	Buruli Ulcer 01/2020 - 06/2003
12	Infections 03/2019 - 09/2004
5	Extensively Drug-Resistant Tuberculosis 01/2019 - 08/2010
4	Critical Illness (Critically Ill) 01/2020 - 01/2014
4	Mycoses (Diseases, Fungus) 08/2019 - 10/2013
4	Inflammation (Inflammations) 03/2019 - 12/2014
4	Ulcer 01/2018 - 09/2003
3	Chronic Obstructive Pulmonary Disease (COPD) 04/2022 - 01/2019
3	Pulmonary Tuberculosis 11/2020 - 01/2019
3	Body Weight (Weight, Body) 01/2020 - 12/2014
3	Pain (Aches) 12/2016 - 01/2015
3	Coinfection 02/2015 - 01/2011
3	Pneumonia (Pneumonitis) 07/2012 - 05/2010
2	Vomiting 01/2022 - 12/2015
2	HIV Infections (HIV Infection) 01/2019 - 01/2017
2	Thrombocytopenia (Thrombopenia) 06/2017 - 02/2010
2	Burns 01/2017 - 01/2017
2	Wounds and Injuries (Trauma) 12/2016 - 01/2015
2	Bronchiectasis 01/2016 - 03/2013
2	Communicable Diseases (Infectious Diseases) 01/2016 - 01/2016
2	Cystic Fibrosis (Mucoviscidosis) 01/2016 - 03/2013
2	Peripheral Nervous System Diseases (PNS Diseases) 08/2010 - 02/2010
2	Human Influenza (Influenza) 03/2010 - 10/2008
2	Necrosis 09/2003 - 06/2003
1	Nausea 01/2022
1	Cicatrix (Scar) 01/2020
1	Breakthrough Infections 01/2020
1	Opportunistic Infections (Opportunistic Infection) 01/2020
1	Overweight 01/2020
1	Granuloma 12/2019
1	Aspergillosis 08/2019
1	Fistula 01/2018
1	Eosinophilia 10/2017
1	Hepatic Encephalopathy 03/2017
1	Rupture 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Chronic Renal Insufficiency 01/2017
1	Diabetes Mellitus 01/2017
1	Bites and Stings (Sting) 01/2017

Drug/Important Bio-Agent (IBA)

35	Pharmaceutical PreparationsIBA 01/2022 - 02/2010
15	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 09/2003
12	Anti-Bacterial Agents (Antibiotics)IBA 10/2019 - 07/2009
9	Linezolid (Zyvox)FDA Link 12/2019 - 02/2010
7	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022 - 08/2015
6	Streptomycin (Streptomycin Sulfate)FDA Link 01/2020 - 02/2010
6	VaccinesIBA 01/2019 - 05/2009
5	Moxifloxacin (Avelox)FDA Link 01/2022 - 06/2011
5	Voriconazole (Vfend)FDA LinkGeneric 03/2019 - 10/2013
5	Levofloxacin (Levaquin)FDA Link 01/2019 - 10/2016
4	Clarithromycin (Biaxin)FDA LinkGeneric 01/2020 - 02/2010
4	posaconazole FDA Link 08/2019 - 10/2013
3	Pyrazinamide FDA LinkGeneric 01/2022 - 11/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2020 - 01/2003
3	EnzymesIBA 03/2019 - 09/2004
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 03/2019 - 12/2014
3	C-Reactive ProteinIBA 01/2019 - 12/2014
3	Carbapenems (Carbapenem Antibiotics)IBA 01/2019 - 04/2016
2	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2019
2	FluoroquinolonesIBA 01/2020 - 01/2018
2	Caspofungin (Cancidas)FDA Link 01/2020 - 01/2017
2	AcidsIBA 12/2019 - 06/2003
2	Glucose (Dextrose)FDA LinkGeneric 02/2019 - 01/2016
2	bedaquiline (R207910)IBA 01/2018 - 02/2016
2	NucleotidesIBA 01/2017 - 01/2014
2	AntigensIBA 01/2017 - 09/2004
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2011
2	Anidulafungin FDA Link 02/2015 - 01/2014
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 03/2014 - 08/2013
2	Indicators and Reagents (Reagents)IBA 02/2010 - 04/2009
2	CytokinesIBA 01/2005 - 09/2003
1	SteroidsIBA 08/2020
1	Volatile Organic CompoundsIBA 08/2019
1	GoldIBA 01/2019
1	Darunavir (Prezista)FDA Link 01/2019
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2019
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2019
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2019
1	Amikacin (A.M.K)FDA LinkGeneric 01/2018
1	Clofazimine (Lamprene)FDA Link 01/2018
1	Interferon Type IIBA 01/2017
1	InflammasomesIBA 01/2017
1	Type VII Secretion SystemsIBA 01/2017
1	Syntex adjuvant formulationIBA 01/2017
1	OxidesIBA 01/2017
1	Advanced Glycation End ProductsIBA 01/2017
1	Ertapenem (Invanz)FDA Link 04/2016

Therapy/Procedure

10	Therapeutics 08/2020 - 07/2006
3	Duration of Therapy 01/2018 - 03/2014
3	Critical Care (Surgical Intensive Care) 03/2017 - 10/2008
2	Length of Stay 10/2017 - 03/2017
2	Injections 12/2016 - 03/2015
2	Enteral Nutrition (Feeding, Tube) 12/2015 - 09/2010
2	Aftercare (After-Treatment) 01/2015 - 07/2009
2	Debridement 01/2013 - 02/2010
1	Drug Tapering 01/2020
1	Electronic Nose 01/2019
1	Precision Medicine 10/2018
1	Pneumonectomy (Lung Volume Reduction) 01/2018